Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
According to our market capitalization data, Eli Lilly (LLY) reached a market cap of $679.94 billion, securing the top spot among global Pharmaceuticals companies. Johnson & Johnson (JNJ) and AbbVie (ABBV) follow closely behind. The data was last updated on April 15, 2025.
| Rank | Name | Market Cap | Price | MCap(30D) | MCap(1Y) | Country |
|---|---|---|---|---|---|---|
|
1
|
 Eli Lilly
LLY
|
$679.94 B | $757.18 |
-8.5%
|
1.7%
|
United States
|
|
2
|
 Johnson & Johnson
JNJ
|
$370.20 B | $153.62 |
-5.2%
|
10.3%
|
United States
|
|
3
|
 AbbVie
ABBV
|
$312.76 B | $176.80 |
-16.5%
|
13.1%
|
United States
|
|
4
|
 Novo Nordisk
NVO
|
$286.98 B | $64.49 |
0.00%
|
-36.7%
|
Denmark
|
|
5
|
 Novo Nordisk A/S
NOVO-B.CO
|
$285.97 B | $64.42 |
0.00%
|
-33.1%
|
Denmark
|
|
6
|
 Roche
ROG.SW
|
$249.63 B | $311.46 |
0.00%
|
33.4%
|
Switzerland
|
|
7
|
 Novartis
NVS
|
$217.12 B | $109.93 |
0.00%
|
13.1%
|
Switzerland
|
|
8
|
 AstraZeneca
AZN
|
$210.42 B | $67.87 |
0.00%
|
-3.7%
|
United Kingdom
|
|
9
|
 Merck
MRK
|
$197.26 B | $78.39 |
-16.5%
|
-34.8%
|
United States
|
|
10
|
 Amgen
AMGN
|
$158.77 B | $295.30 |
-7.3%
|
14.0%
|
United States
|
|
11
|
 Gilead Sciences
GILD
|
$131.74 B | $105.68 |
-5.1%
|
64.2%
|
United States
|
|
12
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B | $500.49 |
-3.5%
|
25.8%
|
United States
|
|
13
|
 Pfizer
PFE
|
$127.27 B | $22.44 |
-15.1%
|
-8.5%
|
United States
|
|
14
|
 Sanofi
SNY
|
$123.58 B | $50.60 |
0.00%
|
12.0%
|
France
|
|
15
|
 Bristol-Myers Squibb
BMY
|
$101.74 B | $50.00 |
-13.5%
|
11.6%
|
United States
|
|
16
|
 CVS Health
CVS
|
$87.00 B | $68.92 |
3.8%
|
4.8%
|
United States
|
|
17
|
 Chugai Pharmaceutical
4519.T
|
$76.38 B | $46.42 |
0.00%
|
32.5%
|
Japan
|
|
18
|
 CSL
CSL.AX
|
$75.00 B | $154.89 |
0.00%
|
-2.5%
|
Australia
|
|
19
|
 GlaxoSmithKline
GSK
|
$72.33 B | $35.68 |
0.00%
|
-17.3%
|
United Kingdom
|
|
20
|
 Zoetis
ZTS
|
$66.56 B | $149.22 |
-8.7%
|
-0.38%
|
United States
|
|
21
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B | $557.91 |
-15.8%
|
-36.1%
|
United States
|
|
22
|
 Merck KGaA
MRK.DE
|
$58.46 B | $134.45 |
0.00%
|
-6.2%
|
Germany
|
|
23
|
 Lonza
LONN.SW
|
$47.74 B | $661.74 |
0.00%
|
14.2%
|
Switzerland
|
|
24
|
 Sun Pharmaceutical
SUNPHARMA.NS
|
$47.28 B | $19.70 |
0.00%
|
17.2%
|
India
|
|
25
|
 Takeda Pharmaceutical
TAK
|
$45.76 B | $14.54 |
0.00%
|
-1.4%
|
Japan
|
|
26
|
 Jiangsu Hengrui Medicine
600276.SS
|
$42.10 B | $6.60 |
0.00%
|
0.22%
|
China
|
|
27
|
 Daiichi Sankyō
4568.T
|
$42.04 B | $22.49 |
0.00%
|
-6.7%
|
Japan
|
|
28
|
 Argenx
ARGX
|
$36.92 B | $605.38 |
0.00%
|
72.5%
|
Netherlands
|
|
29
|
 UCB
UCB.VI
|
$30.04 B | $158.08 |
0.00%
|
53.4%
|
Belgium
|
|
30
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B | $230.93 |
0.00%
|
86.8%
|
United States
|
|
31
|
 Novonesis A/S
NSIS-B.CO
|
$28.92 B | $62.05 |
0.00%
|
7.3%
|
Denmark
|
|
32
|
 Otsuka Holdings
4578.T
|
$25.28 B | $47.74 |
0.00%
|
31.4%
|
Japan
|
|
33
|
 Celltrion
068270.KS
|
$24.33 B | $111.77 |
0.00%
|
11.1%
|
South Korea
|
|
34
|
 BioNTech
BNTX
|
$23.80 B | $99.00 |
0.00%
|
38.8%
|
Germany
|
|
35
|
 Bayer
BAYN.DE
|
$23.13 B | $23.54 |
0.00%
|
-18.2%
|
Germany
|
|
36
|
 BeiGene
BGNE
|
$20.21 B | $230.86 |
0.00%
|
63.9%
|
China
|
|
37
|
 LabCorp
LH
|
$18.91 B | $226.02 |
0.00%
|
22.6%
|
United States
|
|
38
|
 Royalty Pharma
RPRX
|
$18.64 B | $32.45 |
0.00%
|
11.9%
|
United Kingdom
|
|
39
|
 Summit Therapeutics
SMMT
|
$18.16 B | $24.62 |
0.00%
|
370.3%
|
United Kingdom
|
|
40
|
 Sandoz Group
SDZ.SW
|
$17.59 B | $40.85 |
0.00%
|
54.6%
|
Switzerland
|
|
41
|
 Divis Laboratories
DIVISLAB.NS
|
$17.35 B | $65.25 |
0.00%
|
62.5%
|
India
|
|
42
|
 Biogen
BIIB
|
$17.12 B | $116.98 |
0.00%
|
-27.0%
|
United States
|
|
43
|
 Hansoh Pharma
3692.HK
|
$16.95 B | $2.86 |
0.00%
|
16.8%
|
China
|
|
44
|
 Astellas Pharma
4503.T
|
$16.74 B | $9.35 |
0.00%
|
7.4%
|
Japan
|
|
45
|
 Teva Pharmaceutical Industries
TEVA
|
$15.60 B | $13.60 |
0.00%
|
24.1%
|
Israel
|
|
46
|
 West Pharmaceutical
WST
|
$15.36 B | $212.50 |
0.00%
|
-14.4%
|
United States
|
|
47
|
 Baxter
BAX
|
$14.26 B | $27.80 |
0.00%
|
-20.4%
|
United States
|
|
48
|
 Alteogen
196170.KQ
|
$14.16 B | $265.78 |
0.00%
|
145.6%
|
South Korea
|
|
49
|
 Intra-Cellular Therapies
ITCI
|
$14.05 B | $131.87 |
0.00%
|
59.2%
|
United States
|
|
50
|
 Cipla
CIPLA.NS
|
$13.76 B | $17.08 |
0.00%
|
8.4%
|
India
|
|
51
|
 Shionogi
4507.T
|
$13.60 B | $15.98 |
0.00%
|
-1.0%
|
Japan
|
|
52
|
 Insmed
INSM
|
$12.92 B | $71.07 |
0.00%
|
198.7%
|
United States
|
|
53
|
 United Therapeutics
UTHR
|
$12.79 B | $284.82 |
0.00%
|
49.1%
|
United States
|
|
54
|
 Torrent Pharmaceuticals
TORNTPHARM.NS
|
$12.37 B | $36.53 |
0.00%
|
28.0%
|
India
|
|
55
|
 Genmab A/S
GMAB.CO
|
$11.93 B | $195.69 |
0.00%
|
-24.5%
|
|
|
56
|
 Genmab
GMAB
|
$11.92 B | $19.51 |
0.00%
|
-27.6%
|
Denmark
|
|
57
|
 ICON plc
ICLR
|
$11.73 B | $145.16 |
0.00%
|
-36.7%
|
Ireland
|
|
58
|
 Catalent
CTLT
|
$11.52 B | $63.48 |
0.00%
|
13.8%
|
United States
|
|
59
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B | $60.02 |
0.00%
|
-30.1%
|
United States
|
|
60
|
 Incyte
INCY
|
$11.31 B | $58.46 |
0.00%
|
28.3%
|
United States
|
|
61
|
 Recordati
REC.MI
|
$11.26 B | $54.66 |
0.00%
|
24.9%
|
Italy
|
|
62
|
 Mankind Pharma
MANKIND.NS
|
$11.24 B | $27.44 |
0.00%
|
11.3%
|
India
|
|
63
|
 Dr. Reddy's
RDY
|
$11.10 B | $13.32 |
0.00%
|
7.2%
|
India
|
|
64
|
 WuXi Biologics
WXXWY
|
$11.02 B | $5.41 |
0.00%
|
69.3%
|
China
|
|
65
|
 Lupin Limited
LUPIN.NS
|
$10.50 B | $22.99 |
0.00%
|
35.8%
|
India
|
|
66
|
 Exelixis
EXEL
|
$10.23 B | $36.54 |
0.00%
|
46.8%
|
United States
|
|
67
|
 Akeso
9926.HK
|
$10.15 B | $11.31 |
0.00%
|
36.3%
|
China
|
|
68
|
 Moderna
MRNA
|
$10.14 B | $26.24 |
-22.8%
|
-74.2%
|
United States
|
|
69
|
 Zydus Lifesciences
ZYDUSLIFE.NS
|
$10.19 B | $10.14 |
0.00%
|
7.0%
|
India
|
|
70
|
 Neurocrine Biosciences
NBIX
|
$9.51 B | $96.16 |
0.00%
|
-10.7%
|
United States
|
|
71
|
 Walgreens Boots Alliance
WBA
|
$9.38 B | $10.85 |
0.00%
|
-39.5%
|
United States
|
|
72
|
 Swedish Orphan Biovitrum
SOBI.ST
|
$9.28 B | $27.01 |
0.00%
|
23.8%
|
Sweden
|
|
73
|
 Ipsen
IPN.PA
|
$9.27 B | $112.07 |
0.00%
|
12.4%
|
France
|
|
74
|
 Ascendis Pharma
ASND
|
$9.25 B | $153.92 |
0.00%
|
1.8%
|
Denmark
|
|
75
|
 Medpace
MEDP
|
$9.22 B | $305.00 |
0.00%
|
-7.9%
|
United States
|
|
76
|
 Viatris
VTRS
|
$8.93 B | $7.48 |
0.00%
|
-1.5%
|
United States
|
|
77
|
 Sino Biopharmaceutical
1177.HK
|
$8.58 B | $0.48 |
0.00%
|
24.4%
|
China
|
|
78
|
 Cerevel Therapeutics
CERE
|
$8.19 B | $44.96 |
0.00%
|
8.8%
|
United States
|
|
79
|
 Bio-Techne
TECH
|
$8.07 B | $51.07 |
0.00%
|
9.6%
|
United States
|
|
80
|
 Orion Corporation
ORNAV.HE
|
$7.94 B | $56.35 |
0.00%
|
59.1%
|
Finland
|
|
81
|
 kyowa Kirin
4151.T
|
$7.93 B | $15.16 |
0.00%
|
-8.7%
|
Japan
|
|
82
|
 Verona Pharma
VRNA
|
$7.78 B | $58.47 |
0.00%
|
199.0%
|
United Kingdom
|
|
83
|
 Halozyme Therapeutics
HALO
|
$7.57 B | $61.28 |
0.00%
|
49.4%
|
United States
|
|
84
|
 Corcept Therapeutics
CORT
|
$7.34 B | $69.59 |
0.00%
|
188.8%
|
United States
|
|
85
|
 Eisai
4523.T
|
$7.35 B | $26.06 |
0.00%
|
-26.8%
|
Japan
|
|
86
|
 Aurobindo Pharma
AUROPHARMA.NS
|
$7.35 B | $12.64 |
0.00%
|
5.4%
|
India
|
|
87
|
 Abbott India
ABBOTINDIA.NS
|
$7.33 B | $346.02 |
0.00%
|
9.9%
|
India
|
|
88
|
 Roivant Sciences
ROIV
|
$7.18 B | $10.06 |
0.00%
|
2.1%
|
United Kingdom
|
|
89
|
 Madrigal Pharmaceuticals
MDGL
|
$7.09 B | $321.10 |
0.00%
|
44.9%
|
United States
|
|
90
|
 Alkem Laboratories
ALKEM.NS
|
$6.82 B | $57.05 |
0.00%
|
13.3%
|
India
|
|
91
|
 Revolution Medicines
RVMD
|
$6.75 B | $36.32 |
0.00%
|
16.0%
|
United States
|
|
92
|
 BridgeBio Pharma
BBIO
|
$6.51 B | $34.24 |
0.00%
|
25.8%
|
United States
|
|
93
|
 Jazz Pharmaceuticals
JAZZ
|
$6.25 B | $102.91 |
0.00%
|
23.0%
|
Ireland
|
|
94
|
 Legend Biotech
LEGN
|
$6.20 B | $33.74 |
0.00%
|
-28.7%
|
United States
|
|
95
|
 TG Therapeutics
TGTX
|
$6.13 B | $39.03 |
0.00%
|
130.4%
|
United States
|
|
96
|
 Yuhan
000100.KS
|
$5.94 B | $79.38 |
0.00%
|
81.7%
|
South Korea
|
|
97
|
 Grupo Comercial Chedraui SAB de CV
CHDRAUIB.MX
|
$5.79 B | $6.02 |
0.00%
|
4.9%
|
Mexico
|
|
98
|
 Grifols
GRFS
|
$5.71 B | $6.99 |
0.00%
|
8.0%
|
Spain
|
|
99
|
 Ono Pharmaceutical
4528.T
|
$5.65 B | $12.02 |
0.00%
|
-28.0%
|
Japan
|
|
100
|
 Telix Pharmaceuticals
TLX.AX
|
$5.59 B | $16.70 |
0.00%
|
117.2%
|
Australia
|
|
101
|
 Hikma Pharmaceuticals
HIK.L
|
$5.57 B | $2524.99 |
0.00%
|
14.6%
|
United Kingdom
|
|
102
|
 Glaukos
GKOS
|
$5.35 B | $94.52 |
0.00%
|
54.7%
|
United States
|
|
103
|
 Sarepta Therapeutics
SRPT
|
$5.28 B | $54.42 |
0.00%
|
-3.9%
|
United States
|
|
104
|
 ADMA Biologics
ADMA
|
$5.26 B | $22.15 |
0.00%
|
170.5%
|
United States
|
|
105
|
 Richter Gedeon
RIG2.F
|
$5.23 B | $28.67 |
0.00%
|
0.00%
|
|
|
106
|
 Blueprint Medicines
BPMC
|
$5.21 B | $81.45 |
0.00%
|
20.8%
|
United States
|
|
107
|
 Nuvalent
NUVL
|
$5.07 B | $70.78 |
0.00%
|
28.7%
|
United States
|
|
108
|
 Axsome Therapeutics
AXSM
|
$5.06 B | $103.83 |
0.00%
|
84.7%
|
United States
|
|
109
|
 Galenica
GALE.SW
|
$5.02 B | $100.75 |
0.00%
|
18.2%
|
Switzerland
|
|
110
|
 ALK-Abelló
ALK-B.CO
|
$4.91 B | $22.19 |
0.00%
|
22.3%
|
Denmark
|
|
111
|
 Krystal Biotech
KRYS
|
$4.89 B | $169.13 |
0.00%
|
-9.1%
|
United States
|
|
112
|
 Zealand Pharma
ZEAL.CO
|
$4.76 B | $67.35 |
0.00%
|
29.1%
|
Denmark
|
|
113
|
 Siegfried Holding
SFZN.SW
|
$4.72 B | $1078.89 |
0.00%
|
13.4%
|
Switzerland
|
|
114
|
 Alkermes
ALKS
|
$4.61 B | $27.94 |
0.00%
|
51.0%
|
Ireland
|
|
115
|
 Cytokinetics
CYTK
|
$4.60 B | $38.56 |
0.00%
|
-38.8%
|
United States
|
|
116
|
 Glenmark Pharmaceuticals
GLENMARK.NS
|
$4.55 B | $16.09 |
0.00%
|
45.7%
|
India
|
|
117
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B | $28.38 |
0.00%
|
-24.2%
|
United States
|
|
118
|
 Bachem
BANB.SW
|
$4.42 B | $58.90 |
0.00%
|
-27.4%
|
Switzerland
|
|
119
|
 Biocon
BIOCON.NS
|
$4.43 B | $3.70 |
0.00%
|
45.3%
|
India
|
|
120
|
 H. Lundbeck A/S
HLUN-A.CO
|
$4.22 B | $3.72 |
0.00%
|
21.4%
|
Denmark
|
|
121
|
 Lundbeck
HLUN-B.CO
|
$4.19 B | $4.36 |
0.00%
|
28.3%
|
Denmark
|
|
122
|
 Hualan Biological Engineering
002007.SZ
|
$4.11 B | $2.25 |
0.00%
|
-12.6%
|
China
|
|
123
|
 Elanco
ELAN
|
$4.09 B | $8.24 |
0.00%
|
-15.8%
|
United States
|
|
124
|
 China Resources Pharmaceutical Group
3320.HK
|
$4.02 B | $0.64 |
0.00%
|
18.9%
|
Hong Kong
|
|
125
|
 Rhythm Pharmaceuticals
RYTM
|
$3.93 B | $62.09 |
0.00%
|
51.8%
|
United States
|
|
126
|
 Ipca Laboratories
IPCALAB.NS
|
$3.94 B | $15.54 |
0.00%
|
17.8%
|
India
|
|
127
|
 Vaxcyte
PCVX
|
$3.89 B | $30.23 |
0.00%
|
38.1%
|
United States
|
|
128
|
 Laurus Labs
LAURUSLABS.NS
|
$3.82 B | $7.07 |
0.00%
|
31.9%
|
India
|
|
129
|
 Rohto Pharmaceutical
4527.T
|
$3.75 B | $16.60 |
0.00%
|
-5.0%
|
Japan
|
|
130
|
 PTC Therapeutics
PTCT
|
$3.70 B | $46.94 |
0.00%
|
97.0%
|
United States
|
|
131
|
 Perrigo
PRGO
|
$3.42 B | $25.06 |
0.00%
|
-16.6%
|
Ireland
|
|
132
|
 Arcellx
ACLX
|
$3.38 B | $61.43 |
0.00%
|
21.3%
|
United States
|
|
133
|
 Piramal Pharma
PPLPHARMA.NS
|
$3.38 B | $2.57 |
0.00%
|
65.8%
|
India
|
|
134
|
 CRISPR Therapeutics
CRSP
|
$3.34 B | $38.95 |
0.00%
|
-14.2%
|
Switzerland
|
|
135
|
 Amneal Pharmaceuticals
AMRX
|
$3.34 B | $7.17 |
0.00%
|
45.9%
|
United States
|
|
136
|
 Zai Lab
ZLAB
|
$3.33 B | $30.38 |
0.00%
|
90.2%
|
China
|
|
137
|
 Ultragenyx
RARE
|
$3.32 B | $35.34 |
0.00%
|
5.8%
|
United States
|
|
138
|
 Olink Holding
OLK
|
$3.24 B | $26.08 |
0.00%
|
15.1%
|
Sweden
|
|
139
|
 Soleno Therapeutics
SLNO
|
$3.22 B | $70.25 |
0.00%
|
32.9%
|
United States
|
|
140
|
 Avidity Biosciences
RNA
|
$3.21 B | $26.68 |
0.00%
|
43.5%
|
United States
|
|
141
|
 Santen Pharmaceutical
4536.T
|
$3.20 B | $9.38 |
0.00%
|
8.6%
|
Japan
|
|
142
|
 Sinopharm
1099.HK
|
$3.11 B | $2.32 |
0.00%
|
5.1%
|
China
|
|
143
|
 Akero Therapeutics
AKRO
|
$3.03 B | $38.08 |
0.00%
|
134.7%
|
United States
|
|
144
|
 Merus
MRUS
|
$2.99 B | $43.22 |
0.00%
|
-0.27%
|
Netherlands
|
|
145
|
 Jamjoom Pharmaceuticals Factory Company
4015.SR
|
$2.91 B | $41.55 |
0.00%
|
32.8%
|
Saudi Arabia
|
|
146
|
 Laboratorios Farmaceuticos Rovi
ROVI.MC
|
$2.89 B | $56.45 |
0.00%
|
-32.0%
|
Spain
|
|
147
|
 Protagonist Therapeutics
PTGX
|
$2.88 B | $46.95 |
0.00%
|
45.5%
|
United States
|
|
148
|
 Scholar Rock Holding
SRRK
|
$2.87 B | $30.22 |
0.00%
|
172.4%
|
United States
|
|
149
|
 KOBAYASHI Pharmaceutical
4967.T
|
$2.87 B | $38.62 |
0.00%
|
5.1%
|
Japan
|
|
150
|
 Morphic Therapeutic
MORF
|
$2.86 B | $56.99 |
0.00%
|
104.6%
|
United States
|
|
151
|
 Morphosys
MOR
|
$2.86 B | $18.96 |
0.00%
|
5.6%
|
Germany
|
|
152
|
 Organon
OGN
|
$2.85 B | $11.05 |
0.00%
|
-11.5%
|
United States
|
|
153
|
 Catalyst Pharmaceuticals
CPRX
|
$2.83 B | $23.23 |
0.00%
|
46.5%
|
United States
|
|
154
|
 Virbac SA
VIRP.PA
|
$2.82 B | $336.27 |
0.00%
|
-13.4%
|
France
|
|
155
|
 SpringWorks Therapeutics
SWTX
|
$2.82 B | $37.59 |
0.00%
|
24.4%
|
United States
|
|
156
|
 Crinetics Pharmaceuticals
CRNX
|
$2.76 B | $29.66 |
0.00%
|
-16.0%
|
United States
|
|
157
|
 Gland Pharma
GLAND.NS
|
$2.68 B | $16.27 |
0.00%
|
-4.4%
|
India
|
|
158
|
 Immunovant
IMVT
|
$2.63 B | $15.47 |
0.00%
|
-35.8%
|
United States
|
|
159
|
 WuXi AppTec
2359.HK
|
$2.60 B | $6.72 |
0.00%
|
76.0%
|
China
|
|
160
|
 Alvotech
ALVO
|
$2.60 B | $8.60 |
0.00%
|
2.0%
|
Iceland
|
|
161
|
 Viking Therapeutics
VKTX
|
$2.59 B | $23.11 |
0.00%
|
-55.6%
|
United States
|
|
162
|
 Xenon Pharmaceuticals
XENE
|
$2.53 B | $33.03 |
0.00%
|
-6.2%
|
Canada
|
|
163
|
 ACADIA Pharmaceuticals
ACAD
|
$2.50 B | $14.99 |
0.00%
|
10.5%
|
United States
|
|
164
|
 HUTCHMED
HCM
|
$2.46 B | $14.38 |
0.00%
|
-17.3%
|
Hong Kong
|
|
165
|
 ImmunityBio
IBRX
|
$2.45 B | $2.78 |
0.00%
|
-31.1%
|
United States
|
|
166
|
 Apellis Pharmaceuticals
APLS
|
$2.38 B | $18.97 |
0.00%
|
-44.7%
|
United States
|
|
167
|
 Longboard Pharmaceuticals
LBPH
|
$2.34 B | $59.98 |
0.00%
|
228.7%
|
United States
|
|
168
|
 MoonLake Immunotherapeutics
MLTX
|
$2.33 B | $36.77 |
0.00%
|
-0.67%
|
Switzerland
|
|
169
|
 Almirall
ALM.MC
|
$2.27 B | $10.63 |
0.00%
|
15.2%
|
Spain
|
|
170
|
 Recursion Pharmaceuticals
RXRX
|
$2.27 B | $5.64 |
0.00%
|
1.1%
|
United States
|
|
171
|
 Amicus Therapeutics
FOLD
|
$2.12 B | $6.90 |
0.00%
|
-8.7%
|
United States
|
|
172
|
 Vericel
VCEL
|
$2.11 B | $42.01 |
0.00%
|
23.4%
|
United States
|
|
173
|
 Tarsus Pharmaceuticals
TARS
|
$2.04 B | $49.12 |
0.00%
|
48.3%
|
United States
|
|
174
|
 Alembic Pharmaceuticals
APLLTD.NS
|
$1.94 B | $9.88 |
0.00%
|
9.6%
|
India
|
|
175
|
 Apogee Therapeutics
APGE
|
$1.91 B | $32.85 |
0.00%
|
-22.3%
|
United States
|
|
176
|
 Belite Bio
BLTE
|
$1.90 B | $58.88 |
0.00%
|
49.9%
|
United States
|
|
177
|
 Biohaven Pharmaceutical
BHVN
|
$1.89 B | $18.56 |
0.00%
|
-12.6%
|
United States
|
|
178
|
 Mirum Pharmaceuticals
MIRM
|
$1.89 B | $38.63 |
0.00%
|
110.2%
|
United States
|
|
179
|
 Fusion Pharmaceuticals
FUSN
|
$1.83 B | $21.55 |
0.00%
|
0.00%
|
Canada
|
|
180
|
 BB Biotech
BION.SW
|
$1.80 B | $32.95 |
0.00%
|
-9.9%
|
Switzerland
|
|
181
|
 Bavarian Nordic
BAVA.CO
|
$1.78 B | $22.85 |
0.00%
|
18.7%
|
Denmark
|
|
182
|
 Arrowhead Pharmaceuticals
ARWR
|
$1.77 B | $12.87 |
0.00%
|
-15.8%
|
United States
|
|
183
|
 NewAmsterdam Pharma Company
NAMS
|
$1.76 B | $16.06 |
0.00%
|
2.1%
|
Netherlands
|
|
184
|
 Supernus Pharmaceuticals
SUPN
|
$1.76 B | $31.46 |
0.00%
|
28.9%
|
United States
|
|
185
|
 Neuland Laboratories
NEULANDLAB.NS
|
$1.76 B | $137.21 |
0.00%
|
74.0%
|
India
|
|
186
|
 ProKidney
PROK
|
$1.74 B | $0.71 |
0.00%
|
-41.5%
|
United States
|
|
187
|
 Beam Therapeutics
BEAM
|
$1.73 B | $17.28 |
0.00%
|
3.4%
|
United States
|
|
188
|
 Janux Therapeutics
JANX
|
$1.72 B | $29.06 |
0.00%
|
-25.2%
|
United States
|
|
189
|
 PeptiDream
4587.T
|
$1.71 B | $13.17 |
0.00%
|
44.8%
|
Japan
|
|
190
|
 Bausch Health
BHC
|
$1.67 B | $4.52 |
0.00%
|
-29.5%
|
Canada
|
|
191
|
 Sanofi India Limited
SANOFI.NS
|
$1.67 B | $72.37 |
0.00%
|
-33.5%
|
India
|
|
192
|
 Nippon Shinyaku
4516.T
|
$1.66 B | $24.68 |
0.00%
|
-9.5%
|
Japan
|
|
193
|
 Kymera Therapeutics
KYMR
|
$1.65 B | $25.46 |
0.00%
|
6.2%
|
United States
|
|
194
|
 Harmony Biosciences
HRMY
|
$1.65 B | $28.75 |
0.00%
|
27.6%
|
United States
|
|
195
|
 Jubilant Pharmova
JUBLPHARMA.NS
|
$1.63 B | $10.72 |
0.00%
|
38.1%
|
India
|
|
196
|
 Natco Pharma
NATCOPHARM.NS
|
$1.63 B | $9.05 |
0.00%
|
26.6%
|
India
|
|
197
|
 Taro Pharmaceutical
TARO
|
$1.62 B | $42.97 |
0.00%
|
2.2%
|
Israel
|
|
198
|
 Fagron
FAGR.BR
|
$1.60 B | $21.93 |
0.00%
|
13.5%
|
Belgium
|
|
199
|
 Agios Pharmaceuticals
AGIO
|
$1.59 B | $27.82 |
0.00%
|
18.0%
|
United States
|
|
200
|
 Biotest
BIO.F
|
$1.59 B | $47.47 |
0.00%
|
-2.4%
|
Germany
|